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Hand eczema is a disease of long duration, affecting the individual and society. The purpose of this study of 100
patients (51 females and 49 males) at an occupational dermatology clinic was to investigate whether the generic
questionnaire Short Form-36 (SF-36), and the dermatology-speciﬁc Dermatology Life Quality Index (DLQI) are
appropriate for assessing health-related quality of life (HRQL) in patients with hand eczema, and whether gender
differences in HRQL could be detected. HRQL was affected by hand eczema, measured with both SF-36 and DLQI.
The SF-36 showed more impaired HRQL for females than for males, in the mental health dimension, whereas no
gender-related differences were detected with the DLQI. To compare the instruments we used factor analysis, with
a polychoric correlation matrix as input, thus taking the ordinal aspect of the data into account. There was a high
correlation between the instruments for physical health, but lower for mental health. In this context our
interpretation of the factor analysis is that the SF-36 measures mental health better than the DLQI. The SF-36
therefore appears suitable for use in future studies for measuring HRQL, and gender differences in HRQL, in
persons with reported hand eczema.
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Studies of skin diseases and their consequences for the
individual and for society often include measurements of
health-related quality of life (HRQL). When taking the social
dimension of hand eczema into account, it is also important
to analyze the data in a cultural framework (Finlay and Ryan,
1996). Women and men are still subject to different
conditions at home and at work (Meding, 2000; Meding et al,
2001). Consequently, it is appropriate to focus on gender
in data analyses, to elucidate possible gender differences
in HRQL in patients with hand eczema. Hand eczema
accounts for an estimated 90% of occupational skin diseases
(Fregert, 1975; Dickel et al, 2001). In Sweden, about 10% of
the population of working ages have hand eczema at some
time during a year (Meding and Ja¨rvholm, 2002). Exposure to
water and detergents occurs mainly in female-dominated
occupations and in housework, on which women spend
more time than men (Meding, 2000; Meding et al, 2001;
Ha¨renstam et al, 2003). Approximately twice as many women
as men, most of them young and otherwise healthy, suffer
from hand eczema (Meding and Ja¨rvholm, 2002).
Hand eczema is a disease with a remitting and relapsing
course, and of long duration (Meding, 1990; Wallenhammar
et al, 2000). The generic instrument (questionnaire) Short
Form-36 (SF-36) has been used internationally to assess
functional health and well-being, that is, HRQL, in several
long-standing diseases and illnesses (Schlenk et al, 1998;
Mallon et al, 1999; Stavem et al, 2000), well establishing
that people’s daily lives and life satisfaction are affected
negatively. In dermatology, the SF-36 has been used in
acne, atopic dermatitis, and psoriasis (Mallon et al, 1999;
Lundberg et al, 2000; Wahl et al, 2000; Kiebert et al, 2002).
Selected questions from the SF-36 have also been used in
occupational contact dermatitis (Hutchings et al, 2001). The
dermatology-specific Dermatology Life Quality Index (DLQI)
has been used to measure HRQL in skin diseases such
as acne, psoriasis, atopic dermatitis, hyperhidrosis, and
occupational contact dermatitis (Finlay, 1996; Mallon et al,
1999; Lundberg et al, 2000; Hutchings et al, 2001; Swartling
et al, 2001). A modified version has been used in a patch
test clinic population (Holness, 2001). An earlier study has
shown that women report more psychosocial effects of
hand eczema than men (Meding, 1990).
The aims of this study were to investigate whether the
SF-36, and the DLQI were appropriate for assessing HRQL
in patients with hand eczema, and to perform a comparison
of the two instruments, furthermore to study whether gender
differences in HRQL could be detected. Our hypothesis was
that HRQL is impaired by hand eczema.
Results
SF-36 The study group showed statistically significant
impairment in all health domains, physical (PCS) and mental
Abbreviations: BP, bodily pain; DLQI, Dermatology Life Quality
Index; GH, general health; HRQL, health-related quality of life;
MCS, mental component summary score; MH, mental health; PCS,
physical component summary score; PF, physical functioning; RE,
role limitations due to emotional problems; RP, role limitations due
to physical problems; SF, social functioning; SF-36, Short Form 36;
VT, vitality
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component summary score (MCS) compared with the
reference group (n¼1727) (Table I). The question on
perceived change of health during the previous year (the
health transition item), resulted in ‘‘Much better nowy’’
12%, ‘‘Somewhat better nowy’’ 15%, ‘‘About the samey’’
54%, ‘‘Somewhat worse nowy’’ 12% and ‘‘Much worse
nowy’’ 6%, with no differences in distribution between
genders (Wilcoxon’s rank sum test). Females in the study
group had significantly lower scores (more impaired HRQL)
than females in the reference group in all domains, PCS and
MCS, whereas males in the study group, compared with
males in the reference group, had lower scores in RP, BP
and PCS (po0.001). Further, there was a tendency towards
significant results for males in VT and MH (Table I), and
using one-sided tests1 the results are significant VT
(p¼ 0.042), and MH (p¼ 0.044). An analysis of age and
gender (main) effects, in the study group showed that
female gender gave significantly impaired HRQL in PF, VT,
RE, MH, and MCS (Table II). A significant interaction effect
between age and gender was observed for PF and PCS (Fig
1). The significant result was caused mostly by impaired PF
for elderly women. For PF, the main effect for age was also
significant. Even though a significant interaction was
obtained, none of the main effects was significant for PCS.
DLQI (Table III) The sum scores showed varying HRQL
impairment, with a mean  SD score of 7.4  5.8 (range
0–27). There was no statistically significant difference in
distribution between genders (Wilcoxon’s rank sum test),
females 7.3  6.3 (range 0–25), and males 7.5  5.3 (range
0–27). For comparison, the median score was 6 (females
six, males six). For testing age and gender effects, and
possible interaction, a logistic regression analysis was
used. It revealed neither significant main effects of age
and gender nor any interaction effects on DLQI dichot-
omized total score. Regarding DLQI category scores
‘‘symptoms and feelings’’ and ‘‘work/school’’ were signifi-
cantly higher than the other categories, and ‘‘personal
relationships’’ significantly lower (Wilcoxon’s signed rank
test) (Fig 2). Within the categories, no statistically significant
gender differences were seen.
Factor analysis, DLQI First, a hypothesis was formed as
to how far physical and mental health is reflected in the
DLQI instrument question content. Then a polychoric
correlation matrix (DLQI), (Table IV), was used as input in
an exploratory factor analysis with promax rotation (correla-
tion between the underlying factors allowed). The explora-
tory factor analysis and the hypothesis principally agreed,
that is, two underlying dimensions (labelled ‘‘physical’’ and
‘‘mental’’) were identified. Next, a confirmatory factor
analysis based on the (slightly revised) hypothesis accord-
ing to Fig 3 was evaluated. Note that if there is no arrow
between an unobserved factor and an observed DLQI
variable, the factor loading is set to zero. For example,
between DLQI 3 and ‘‘mental’’ there is no arrow, implying no
association. The correlation between ‘‘physical’’ and PCS
was 0.53, and that between ‘‘mental’’ and MCS was
0.25. The correlation is negative because high positive
values represent good health for the SF-36 but impaired
Table I. Differences in the SF-36 domain and component
summary scoresa between the hand eczema group (n¼ 100),





PF 85.2  17.0 89.4  17.4 0.018
RP 55.8  41.3 84.2  30.9 o0.001
BP 59.1  28.4 74.2  26.4 o0.001
GH 69.8  21.1 75.4  22.8 0.011
VT 59.2  23.6 68.4  22.9 o0.001
SF 81.1  25.0 87.7  21.1 0.012
RE 74.0  38.1 85.8  29.1 0.003
MH 73.6  19.5 80.3  19.5 0.001
PCS 45.3  9.3 50.6b  9.1 o0.001
MCS 46.4  11.8 49.7b  10.5 0.007
Females (n¼51) Females (n¼ 880)
PF 80.3  20.6 88.3  17.6 0.009
RP 52.0  41.5 83.6  31.1 o0.001
BP 60.4  30.4 72.3  26.4 0.009
GH 67.7  21.3 75.4  22.6 0.014
VT 53.0  25.2 66.0  23.2 0.001
SF 76.7  29.3 86.8  21.7 0.019
RE 64.1  42.1 84.1  30.7 0.002
MH 70.0  21.6 79.2  19.7 0.005
PCS 44.8  10.1 50.3b  9.1 o0.001
MCS 43.5  13.0 49.1b  10.9 0.004
Males (n¼49) Males (n¼ 847)
PF 90.4  10.1 90.7  17.1 0.862
RP 59.7  41.1 84.8  30.8 o0.001
BP 57.7  26.5 76.2  26.4 o0.001
GH 72.1  20.8 75.4  23.0 0.278
VT 65.6  20.1 70.9  22.4 0.083
SF 85.7  18.9 88.6  20.5 0.301
RE 84.4  30.5 87.5  27.2 0.480
MH 77.3  16.5 81.6  19.2 0.088
PCS 45.9  8.4 50.9b  9.1 o0.001
MCS 49.4  9.6 50.4b  10.0 0.504
aSF-36 domains and component summary scores: physical functioning
(PF), role limitations due to physical problems (RP), bodily pain (BP),
general health (GH), vitality (VT), social functioning (SF), role limitations
due to emotional problems (RE), mental health (MH), physical component
summary score (PCS), mental component summary score (MCS).
b¼ 795 (females), 765 (males). Data are expressed as mean  SD.
ca p-value is based on a t-test for equal means assuming unequal
variances using Satterthwait’s approximation (Satterthwait, 1946).
1The null hypothesis was that the mean scores for VT and MH,
in each population (study group and reference group), were equal,
and the alternate hypothesis was that the mean scores for VT and
MH, were lower for the study group than for the reference group.
1382 WALLENHAMMAR ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
health for DLQI. Both are significantly different from zero.
The factor loadings for the variables associated both with
‘‘mental’’ and ‘‘physical’’ are 0.58 or higher (all loadings
differ significantly from zero). To improve the model fit, error
variances between the (observed) DLQI questions were
allowed to correlate. For the final model, the p-value in a
goodness-of-fit test was 0.1. This means that there was
some, but not enough, evidence (indication) that the data
and the model disagree; hence we cannot reject the
hypothesis that the data and model agreed. All results
should be interpreted bearing in mind that the sample size is
(only) 100 patients. Hence, some caution is advisable since
the sample size may be too small for the factor analysis.2
Discussion
‘‘y most people regard other people’s skin disease as
trivial, but those with skin disease at some time in their life
never regard it as trivial’’, says Ryan (1987). Several studies
have also shown that HRQL is affected in many skin
diseases, although little has been mentioned as regards
possible gender differences. The present project was
initiated to measure how hand eczema affects HRQL in
women and men. Here we evaluated SF-36 and DLQI, and
our hypothesis that HRQL is affected by hand eczema was
confirmed. Moreover, gender differences were detected
with the SF-36. Our results, however, are based on data
obtained from 100 patients at an occupational dermatology
Table II. Effects of age and gender on the SF-36 domains and component summary scoresa, with p-values presented for each
variable. Analysis performed using ANOVA
PF RP BP GH VT SF RE MH PCS MCS
Gender 0.005b 0.294 0.623 0.233 0.004b 0.057 0.004b 0.037b 0.843 0.005b
Age 0.019 0.529 0.985 0.417 0.100 0.400 0.222 0.146 0.641 0.125
aSF-36 domains and component summary scores: physical functioning (PF), role limitations due to physical problems (RP), bodily pain (BP), general
health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), mental health (MH), physical component summary score
(PCS), mental component summary score (MCS).



























Significant interaction effects of age and gender. For PF, p¼0.019
and for PCS, p¼0.020.
Table III. Frequency distribution for each DLQI question
Values
0 1 2 3 Total
DLQI 1 9 36 33 22 100
DLQI 2 49 32 13 6 100
DLQI 3 44 28 22 6 100
DLQI 4 77 16 4 3 100
DLQI 5 58 25 11 6 100
DLQI 6 67 21 6 6 100
DLQI 7 31 28 19 22 100
DLQI 8 73 17 6 4 100
DLQI 9 85 11 2 2 100
DLQI 10 53 34 11 2 100
Figure2
DLQI category scores for women and men. The scores are
expressed as percentages to enable comparisons between categories.
A Wilcoxon signed rank test for testing if the distribution of the pairwise
difference between two DLQI categories is centered at zero showed
significant result for ‘‘symptoms and feelings’’ versus all other
categories (except ‘‘work/school’’), and significant result for ‘‘work/
school’’ versus all other categories (except ‘‘symptoms and feelings’’).
A significant result was also obtained for the category ‘‘personal
relationships’’ versus all other categories.
2For example, even though the factor loadings are significantly
different from zero this does not necessarily imply that the sample
size is sufficient.
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clinic, and should be confirmed in other study populations.
In a public health perspective, it is important to obtain
fundamental data on HRQL in hand eczema, as an
important part in the assessment of results of medical
treatment, sick-leave, change of occupation (occupational
tasks) and preventive measures. We compare two well-
established methods for measuring HRQL, and our intention
is to study how they reflect the underlying factors, which
affect self-reported HRQL. Our intention is to use the SF-36
in a large-scale survey of the general population regarding
gender differences in hand eczema, as our results indicate
that impaired HRQL can be measured with this instrument,
and that gender differences can be detected.
To correlate the instruments, we performed a factor
analysis (DLQI). The main value of factor analysis is that it
gives the investigator insight into the interrelationships
present in the variables and offers a method for summariz-
ing them. The major emphasis is placed on obtaining easily
understandable factors that convey essential information
contained in the original set of variables. Mainly, applica-
tions have come from the social sciences, particularly
psychometrics (Afifi and Clark, 1997). The DLQI has not
been factor analyzed (Finlay and Khan, 1994), hence the six
categories were formed on a ‘‘common sense’’ basis (Finlay
et al, 1990; Kent and Al-Abadie, 1993; Finlay and Khan,
1994). Kent and Al-Abadie (1996), however, performed a
factor analysis on the DLQI results in vitiligo, and found
three factors accounting for 61.5% of the variance. Further,
a factor analysis of the Psoriasis Disability Index, gave two
factors accounting for 54.8% of the variance (Kent and Al-
Abadie, 1993). In the French questionnaire VQ Dermato,
seven factors explained 72% of the total variance of
the correlation matrix (Grob et al, 1999). Finally, in the
development of Skindex, seven factors accounted for 78%
of the common variance of the correlation matrix (Chren
et al, 1996), and in the refined version of Skindex, 97% of
Table IV. Polychoric correlation matrix for the DLQI questions
DLQI 1 DLQI 2 DLQI 3 DLQI 4 DLQI 5 DLQI 6 DLQI 7 DLQI 8 DLQI 9 DLQI 10
DLQI 1 1.00
DLQI 2 0.64 1.00
DLQI 3 0.50 0.34 1.00
DLQI 4 0.56 0.59 0.26 1.00
DLQI 5 0.47 0.63 0.64 0.35 1.00
DLQI 6 0.43 0.54 0.52 0.29 0.59 1.00
DLQI 7 0.49 0.59 0.68 0.42 0.65 0.42 1.00
DLQI 8 0.42 0.53 0.60 0.43 0.67 0.40 0.60 1.00
DLQI 9 0.41 0.72 0.53 0.43 0.79 0.53 0.53 0.78 1.00
DLQI 10 0.50 0.49 0.63 0.18 0.51 0.31 0.59 0.60 0.53 1.00
Figure 3
Conceptual path diagram, together with esti-
mates, for the confirmative factor analysis model
for the DLQI instrument combined, in the same
model, with MCS and PCS from the SF-36
instrument. The boxes illustrate observed variables
and circles illustrate unobserved variables or dimen-
sions. The arrows represent the associations, and a
variable at the base of the arrow ‘‘causes’’ the
variable at the head of the arrow. The (small) arrows
to the left of the DLQI variables and to the right of
MCS and PCS, respectively, represent measurement
errors. The figures on the arrows connecting
‘‘mental’’ and ‘‘physical’’ with the observed DLQI
questions represent estimated factor loadings. The
estimated correlation between ‘‘mental’’ and MCS is
0.25, and 0.53 between ‘‘physical’’ and PCS.
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the common variance was explained by three factors (Chren
et al, 1997). We chose to use two factors, because in the
confirmatory, two-factor, analysis model, there was good
agreement between the data and the model. The correlation
analysis between the SF-36 and DLQI resulted in a
high correlation between the two underlying physical
health dimensions, and low correlation between the two
mental dimensions. Different interpretations concerning the
measurement of the mental dimension are possible, such as
that the DLQI might measure other mental aspects than the
SF-36 does, or that the DLQI measures mental health to a
lesser extent. As females compared with males reported
more impaired mental health with the SF-36 but not with the
DLQI, our results indicate that the SF-36 was superior to the
DLQI for measuring mental aspects of HRQL.
SF-36 Generic health questionnaires have several impor-
tant advantages. Thus they allow comparisons between
diseases of different organs, and consequently also
between different skin diseases (Mallon et al, 1999;
Lundberg et al, 2000; Kiebert et al, 2002). Results from
other studies mainly show mental health impairment: after
adjustment for age and gender, acne patients had sig-
nificant impairments in MH, SF, VT, and RE, compared with
the general population (Mallon et al, 1999). After adjust-
ments for age, gender, and educational level, psoriasis
patients reported significantly lower scores than the normal
controls in all domains, with the greatest differences in RE,
RP, and BP (Wahl et al, 2000), whereas patients with atopic
dermatitis had lower scores in VT, SF, and MH than the
general population did (Kiebert et al, 2002). Our results
suggest that women and men are affected differently. Our
study group women reported more impaired HRQL in all
domains that are connected with mental health. This implies
that hand eczema in women has a greater impact on their
mental health, which can be because women and men are
subjected to different conditions at home and at work
(Mallon et al, 1999), women and men having different
household and nursing responsibilities (Ha¨renstam et al,
2003) and different wet exposure (Meding, 2000; Meding
et al, 2001). Furthermore, personal characteristics such as
individual experience of the skin lesions, and the location of
the skin disease, for example, face and hands (Grob et al,
1999) also can affect the HRQL reported. It was not
possible to control for diseases in the reference group.
That the individuals in the study group could have other
diseases/illnesses at the same time, affecting the outcome
in HRQL, should also be remembered when the results are
evaluated.
DLQI The DLQI instrument was designed to measure
disability caused by any skin disease, and used as an
assessment tool in routine daily clinical practice (Finlay and
Khan, 1994). It allows for comparisons between different
skin diseases. The DLQI sum score in this study is similar
to scores previously found for other skin diseases, for
example, acne, atopic dermatitis, and psoriasis (Mallon
et al, 1999; Lundberg et al, 2000; Kiebert et al, 2002).
Thomson et al (2002) examining quality of life by body site,
found a DLQI median of 5 (0–23) for the hands (41 patients,
not divided by gender). We detected no gender differences
in the distribution of the DLQI sum scores, which is
consistent with results from other studies (Finlay, 1996;
Kent and Al-Abadie, 1996; Mallon et al, 1999; Hutchings
et al, 2001). Nor did we find any gender differences in the
distribution of the DLQI category sum scores, or any effects
of age and gender on the results in the group studied. That
highest DLQI category sum score was found in ‘‘work/
school’’ and ‘‘symptoms and feelings’’ was expected
because sore hands affect working performance. Lowest
score in the category ‘‘personal relationships’’ might be due
to the forward question content.
Methodological aspects In this study, we took the ordinal
aspects of the data into account, and we present a new
model for correlating the SF-36 to the DLQI, that is, a factor
analysis with a polychoric correlation matrix as input
(Jo¨reskog and So¨rbom, 1993). An issue that needs to be
discussed in this context concerns the treatment of the
scale characteristics for the DLQI. When estimating the
model in Fig 3, a covariance or correlation matrix between
the observed variables served as input in the analysis.
Regarding the scale for the DLQI instrument as interval and
calculating the ordinary Pearson correlation between pairs
of variables, is questionable. Nor is the Spearman rank
correlation appropriate in this situation (Olsson, 1979).
Instead the polychoric correlation can be warranted. By
using the polychoric correlation we impose no other
assumption on the scale than its ordinal characteristics.
This is also true for the Spearman correlation, but since the
thresholds are allowed to vary (i.e., are estimated) when
estimating the polychoric correlation, the Spearman corre-
lation is apt to be a biased estimator for the polychoric
correlation. Hence, we advocate the use of the polychoric
correlation rather than the Pearson and Spearman correla-
tion in this situation.
Dichotomizing the DLQI variables (factor analysis) The
reason for dichotomizing the DLQI variables was that, for
most of the questions, the variability over all four-scale
alternatives was low. In particular, for many questions the
scale alternatives ‘‘A lot’’ and ‘‘Very much’’ were seldom
used. Hence, keeping all four scale alternatives might lead
to numeric instability. By dichotomizing the scale, we gave
up some information, but the polychoric correlation became
more stable. The reason for treating DLQI 1 differently from
the other DLQI questions was that, since the study group
mainly consisted of patients with ongoing hand eczema
(only eight patients had no objective signs of hand eczema
on examination), the category ‘‘Not at all’’ was infrequent for
DLQI 1.3 Using the same categorization scheme for DLQI 1
as for the other variables, would have led to a variable
without variation (almost everybody would have ended up in
the category ‘‘Presence of skin-related problems’’).
Conclusion In conclusion our results indicate that HRQL is
affected by hand eczema, measured with both SF-36 and
DLQI. The SF-36 showed more impaired HRQL for females
than males, in the mental health dimension, whereas we
3DLQI 1 wording is ‘‘Over the last week, how itchy, sore, painful
or stinging has your skin been?’’.
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detected no gender-related difference with the DLQI. There
is a high correlation between the instruments in physical
health, but lower in mental health. Thus, in this context, our
interpretation of the factor analysis is that an advantage of
the SF-36 is to measure mental health to a greater extent
than the DLQI does. We therefore suggest that, in future
studies, the SF-36 is suitable for measuring HRQL and
gender differences in HRQL in persons with reported hand
eczema.
Subjects and Methods
Study group One hundred and five patients, consecutively
referred to the Department of Occupational and Environmental
Dermatology, Stockholm County Council, with a referral diagnosis
of hand eczema, were invited to participate. One hundred patients
attended the study visit to the clinic, and all had their hand eczema
diagnosis confirmed by assessment of clinical signs and history.
The study group consisted of 51 females with a mean age of 41 y
(range 20–64), and 49 males with a mean age of 42 y (range 19–64).
For analysis, data were divided into three age groups:o30 y (f 12,
m 14), 30–49 y (f 24, m 17), 50–64 y (f 15, m 18). Eighty-seven
percent (46 females, 41 males) were categorized as first visits
(referrals) and 13% (five females, eight males) as returning visits
to the clinic, between May 2000 and January 2001. Among those
who did not attend, four refused to participate and one failed
to complete the questionnaires. The study was approved by the
Ethics Committee of the Karolinska Institutet, Stockholm. Partici-
pants in the study gave their informed consent according to the
Declaration of Helsinki principles.
Hand eczema diagnosis The diagnosis of hand eczema included
allergic contact dermatitis, irritant contact dermatitis, atopic hand
eczema, hyperkeratotic palmar eczema, pompholyx, and unclas-
sified hand eczema. Morphological criteria for eczema were
defined as a past or present history of erythema and papules/
vesicles, or of erythema, scaling, and fissures, with or without
papules/vesicles. Eight patients (six females, two males) had a
history of hand eczema, but no objective signs when examined.
Quality of life questionnaires A postal invitation to participate in
the study, and the questionnaires SF-36 and DLQI, were enclosed
with the invitation to the doctor’s appointment. If the patient
accepted to participate, she/he was asked to complete the SF-36,
and the DLQI at home, preferably the day before visiting the clinic.
Immediately after the doctor’s consultation, the patients were
invited to the dermatologist in charge of the study (L-MW or ML),
where they were asked to complete any missing questionnaire
items. Here also a hand eczema diagnosis, past or present, was
assessed.
SF-36 The SF-36 is a generic short-form measure of functional
health and well-being, where respondents are asked about their
health over the previous 4 wk. It has been extensively applied in
comparing general and specific populations, estimating the burden
of disease and measuring the effectiveness of treatments (Ware
and Sherbourne, 1992; Ware et al, 1993). The Swedish version was
first made available in 1992, and Swedish population norms were
published in 1994 (Sullivan and Karlsson, 1994; Sullivan et al,
1995). It consists of 36 questions measuring eight health domains,
related to a physical and mental health dimension: physical
functioning (PF, 10 questions), role limitations due to physical
problems (RP, four questions), bodily pain (BP, two questions),
general health (GH, five questions), vitality (VT, four questions),
social functioning (SF, two questions), role limitations due to
emotional problems (RE, three questions), mental health (MH, five
questions), and a question about perceived change of health
during the last year. A score between 0 (worst) and 100 (best) is
calculated for each domain using a standardized scoring system
(Ware et al, 1993; Sullivan and Karlsson, 1994). Thus, eight scales,
hereafter referred to as health indices are formed. Using factor
analysis, it is also possible to estimate a physical (PCS) and mental
component summary score (MCS), on the basis of the eight
domains previously described (Ware et al, 1995).
DLQI The DLQI questionnaire is dermatology specific. Respon-
dents are asked about the effect, over the previous week, of skin
disease on their lives (Finlay and Khan, 1994). It contains 10 items,
labelled DLQI 1-10 (see Appendix), that comprise six categories:
symptoms and feelings (DLQI 1, 2), daily activities (DLQI 3, 4),
leisure (DLQI 5, 6), work/school (DLQI 7), personal relationships
(DLQI 8, 9), and treatment (DLQI 10). Total sum score can range
from 0 to 30; the higher the score, the greater the disability. We
used a validated Swedish translation of the DLQI, provided by
Professor A.Y. Finlay, UK.
Standardization for age and gender The Swedish SF-36
normative database, that is, the Swedish norm population,
consists of 8930 subjects, 4582 females (52%) and 4268 males
(48%) (Sullivan and Karlsson, 1994; Sullivan et al, 1995). For
comparison with our study group, we ordered a sample matched
for age and gender from the HRQL group, which handles the
Swedish SF-36 normative database at the Sahlgrenska University
Hospital, Go¨teborg. This reference group consisted of 1727
persons (880 females and 847 males).
Statistical methods One general aspect regarding the instru-
ments SF-36 and DLQI, which has implications for statistical
analysis, concerns the measurement scales. The rating scales in
both questionnaires can be viewed as ordinal scales, since the
numeric values assigned to each scale alternative are arbitrary. It is
usual, however, to assign metric values to the scale alternative and,
at least for SF-36, the scale (and the derived eight health indices
and two component summary scores) are traditionally regarded as
interval. Some authors, however, question this approach (Svens-
son, 2001). In this paper we use, whenever possible, methods that
only take the ordinal aspects of the data into account. Whenever a
significant result is mentioned in the text, the p-value for the test
is below a 5% significance level, and all tests are two-sided, un-
less otherwise mentioned. The eight health indices (and the two
component summary scores) in SF-36 were calculated according
to a SAS program, provided by the HRQL group. The six categories
in the DLQI instrument were calculated according to Finlay and
Khan (1994).
For comparing the study group and the reference group
concerning the SF-36 (eight domains, two component summary
scores), we used a two-sample t-test for independent samples (a
non-parametric test, for example, a Wilcoxon rank sum test, was
not possible because only mean values and SD for the reference
group were provided by the HRQL group). Within the study group,
when testing the age and gender effect (and possible interaction)
on the SF-36 (eight domains, two component summary scores), we
used ANOVA with the Tukey–Cramer correction for post hoc
comparisons. For testing if the distribution of the pairwise
difference between two DLQI categories is centered at zero, we
used Wilcoxon’s signed rank test.
Regarding the DLQI instrument, the total score for each
individual was a simple sum score over the 10 questions (Finlay
and Khan, 1994). Summing scores, however, assumes that they
are measured on an interval scale. This can, as mentioned above,
be questioned. We therefore dichotomized the sum score into high
(impaired) and low HRQL (cut-off 14 or larger).4 For testing age and
gender effect on (and possible interaction with) the dichotomized
sum score we used logistic regression. The six DLQI categories
were also formed as sum scores (Finlay and Khan, 1994). For
4We also tried the median as a cut-off point for the sum score.
The results with the two different cut-off points were equivalent.
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presentation, however, the scores are presented as percentages
of maximum attainable score. The same aspects concerning the
assumed interval characteristics of the scale as mentioned above
for the whole DLQI sum score, also apply here. With this in mind,
we performed a Wilcoxon rank sum test of the equality of
distribution between genders for the total score and the six
categories.
Both the DLQI and the SF-36 measure self-reported aspects of
HRQL. To assess whether the two instruments correlate, factor
analysis is a potential methodological framework. In factor analysis
the correlation structure between observed (or manifest) variables
is analyzed in order to identify (few) underlying (unobservable)
dimensions or factors. Since both the DLQI and the SF-36 are
intended to measure the unobservable dimension HRQL, factor
analysis was used to assess the association between the observed
variables and this dimension. For SF-36, extraction of two
component summary scores (MCS and PCS), with factor analysis
from the eight health domains is well established (Sullivan and
Karlsson, 1994; Ware et al, 1995), whereas these issues are little
known for DLQI (Kent and Al-Abadie, 1993; Finlay and Khan, 1994),
with one exception in the literature (Kent and Al-Abadie, 1996).
Before presenting our use of factor analysis, we briefly review
some of its fundamentals. A good introductory text on its use when
studying quality of life is found in Fayers and Machin (2000). Factor
analysis can be either exploratory or confirmatory. In exploratory
factor analysis the relationship among the observed variables and
the underlying (unobserved) factors is analyzed in an explorative
fashion, that is, neither the number of factors nor the relationship
between the factors and the observed variables is specified in
advance. The purpose of the exploratory analysis is to determine
the number of factors and their relationships to the observed
variables. If each observed variable is uncorrelated with all the
other variables, we need as many factors as observed variables to
describe the correlation structure. If some variables correlate,
however, we can describe their correlation structure with (hope-
fully) few factors. In exploratory factor analysis ‘‘eigenvalues’’ are
often used to assess the number of factors. Eigenvalues are
obtained by a mathematical operation, and their exact definition
is complex, but a rough interpretation is that they constitute a
measure of how much of the variation in the data is accounted for
by each factor. Thus they indicate the importance of each factor in
explaining the variability, and the correlations, in the observed
sample of data. The relationship between a factor and an observed
variable is expressed by a ‘‘factor loading’’, which is a coefficient5
scaled between 1 and 1. The coefficient is often interpreted as
the correlation between a factor and the observed variable. The
observed variables with high factor loadings (i.e., high correlations)
on the same factor are often used to name the factor.
In confirmatory factor analysis, on the other hand, the number
of factors and their relationships to the observed variables are
specified in advance. By forming a hypothesis, a model of the
structure of the relationship between the factors and the observed
variables is specified. Notably, some factor loadings are restricted
to zero, implying no association between the factor and the
observed variable. Once the model is formulated we can estimate
it,6 and one purpose of the analysis is to test, or confirm, how well
the data fit the hypothesized structure. The test of the model is a
goodness-of-fit test (Jo¨reskog and So¨rbom, 1993, p 117), the
model being accepted as adequate provided there is no strong
counter-evidence against it. The means for evaluating a confirma-
tory factor analysis model is thus quite different from that for
exploratory factor analysis. For example, the percentage of the
variance explained by the largest eigenvalues is not used in
confirmatory factor analysis to assess the adequacy of the model.
Fayers and Machin (2000) point out that confirmatory factor
analysis has, as yet, been little practised in the study of quality of
life, but is likely to be a ‘‘yfar more appropriate approach’’ than
exploratory factor analysis.
Based on expertise concerning which of the DLQI questions
ought to measure the same underlying dimension, combined with
an exploratory factor analysis, a confirmatory factor analysis model
was formulated for this study. The relationships between the
variables in the model are visualized, together with estimates, in a
path diagram in Fig 3. The factor model (measurement model)
for the DLQI instrument (Fig 3, left) contains two unobserved
dimensions, physical and mental components, hereafter referred to
as ‘‘physical’’ and ‘‘mental’’. It is tradition to illustrate unobserved
dimensions with circles, as opposed to observed variables, which
are illustrated as boxes. This factor model was then combined with
an additional measurement model for the SF-36 instrument
consisting of the two observed component summary scores,
MCS and PCS7 (Fig 3, right). Fig 3 suggests that MCS and PCS are
simultaneously unobserved and observed. This is actually not the
case. The arrow connecting the circle and box for MCS and PCS,
respectively, is set to identity, that is, the circle MCS (PCS) and the
box MCS (PCS) are identical. Thus we obtain (estimates of) the
correlation between the underlying dimensions ‘‘physical’’ and
PCS on the one hand and between ‘‘mental’’ and MCS on the
other. For estimating the model in Fig 3, we used the software
LISREL (Jo¨reskog and So¨rbom, 1993) with a polychoric correlation
matrix as input in the analysis.
Polychoric correlation As Fayers and Machin (2000) point out, both
exploratory and confirmatory factor analysis have problems in
handling (ordered) categorical data. If the measurement scale is
ordinal, assigning numerical values to the scale alternatives and
calculating the (ordinary) Pearson correlation as input in the factor
analysis is a questionable approach, but this is usually what
standard software does by default. Nor is the use of the Spearman
rank correlation recommended (see Discussion). To overcome
these problems, the polychoric correlation method is suggested.
An introductory reference to polychoric correlation is available on
the Internet.8 Its theoretical starting point is that an observed
(categorical) variable may be regarded as a crude measurement for
an underlying unobserved or unobservable, continuous, variable.
For example, for question DLQI 1 ‘‘Over the last week, how itchy,
sore, painful or stinging has your skin been?’’, the rating scale
ranges from 0 ‘‘Not at all’’ to 3 ‘‘Very much’’. Here, the underlying
variable corresponding to this can be seen as continuous, but is
manifested by a rating value 0, 1, 2 or 3. We now formulate this
more formally.
An ordinal (categorical) variable x may be regarded as a crude
measurement for an underlying unobserved or unobservable,
continuous, variable x. For example the four-point rating scale
in the DLQI questionnaire might be conceived as
if xpt1, x is scored 0 (answer alternative,‘‘Not at all’’),
if t1oxpt2, x is scored 1, alternatively ‘‘A little’’,
if t2oxpt3, x is scored 2, alternatively ‘‘A lot’’,
if t3ox, x is scored 3, alternatively ‘‘Very much’’.
Here t1ot2ot3 are threshold values for x. In the case of two
ordinal variables x1 and x2, we can assume that the two underlying
continuous variables x1 and x

2 follow an underlying bivariate
normal distribution. The correlation between x1 and x

2 is called the
polychoric correlation. Since we only observe the (ordered)
categorical values for x1 and x2, by forming a two-way contingency
table we can estimate the polychoric correlation (as well as the
5Resembles a regression coefficient.
6The estimation can for example be made by the maximum
likelihood method.
7When two measurement models are combined into one single
(total) model, this single model is sometimes called a structural
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thresholds ti). The assumption of an underlying bivariate normal
distribution can be tested with a goodness-of-fit test (i.e., a w2-test).
Before the polychoric correlation between the DLQI questions
was calculated, each question (except DLQI 1) was dichotomized.
‘‘Not at all’’, became a new category ‘‘Absence of skin-related
problems’’, and ‘‘A little’’, ‘‘A lot’’ and ‘‘Very much’’ became
‘‘Presence of skin-related problems’’. For question DLQI 1, ‘‘Not at
all’’ and ‘‘A little’’ formed the new category ‘‘Absence or mild skin-
related problems’’ and ‘‘A lot’’ and ‘‘Very much’’ became ‘‘Presence
of skin-related problems’’.
The factor analysis was performed using the LISREL software
version 8.52. For all other analyses we used the SAS system
release 8.2.
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Appendix
Questions from the DLQI (Finlay and Khan, 1994). Each
question has four answer alternatives (see Statistical
methods). The DLQI questions are reproduced by permis-
sion of the copyright holders.
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1 Over the last week, how itchy, sore, painful or stinging
has your skin been?
2 Over the last week, how embarrassed or self-conscious
have you been because of your skin?
3 Over the last week, how much has your skin interfered
with you going shopping or looking after your home or
garden?
4 Over the last week, how much has your skin influenced
the clothes you wear?
5 Over the last week, how much has your skin affected
any social or leisure activities?
6 Over the last week, how much has your skin made it
difficult for you to do any sport?
7 Over the last week, has your skin prevented you from
working or studying?
8 Over the last week, how much has your skin created
problems with your partner or any of your close friends
or relatives?
9 Over the last week, how much has your skin caused any
sexual difficulties?
10 Over the last week, how much of a problem has the
treatment for your skin been, for example by making
your home messy, or by taking up time?
rAY Finlay, GK Kahn, April 1992. This must not be
copied without the permission of the authors.
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